1. Home
  2. VPG vs RZLT Comparison

VPG vs RZLT Comparison

Compare VPG & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vishay Precision Group Inc.

VPG

Vishay Precision Group Inc.

N/A

Current Price

$48.90

Market Cap

968.7M

Sector

Technology

ML Signal

N/A

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

N/A

Current Price

$4.20

Market Cap

352.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VPG
RZLT
Founded
2009
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
968.7M
352.1M
IPO Year
2010
2011

Fundamental Metrics

Financial Performance
Metric
VPG
RZLT
Price
$48.90
$4.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
11
Target Price
★ $74.33
$10.80
AVG Volume (30 Days)
296.1K
★ 1.5M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 23.47
EPS
★ N/A
N/A
Revenue
★ $307,202,000.00
N/A
Revenue This Year
$12.08
N/A
Revenue Next Year
$7.69
$2,410.31
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 0.22
N/A
52 Week Low
$29.14
$1.07
52 Week High
$151.78
$11.17

Technical Indicators

Market Signals
Indicator
VPG
RZLT
Relative Strength Index (RSI) 41.47 52.90
Support Level $41.35 $3.58
Resistance Level $61.50 $4.22
Average True Range (ATR) 3.77 0.39
MACD 0.43 0.04
Stochastic Oscillator 52.75 60.24

Price Performance

Historical Comparison
VPG
RZLT

About VPG Vishay Precision Group Inc.

Vishay Precision Group Inc manufactures and markets sensors and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.

Share on Social Networks: